Weekly Policy Update: CBSA Lays Groundwork for Upcoming 2022 Session
By: Colorado BioScience Association Date: 07/27/2021
Colorado BioScience Association (CBSA) leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal polici...
Learn MoreA Message from President & CEO Jennifer Jones Paton on her Transition from CBSA
By: Colorado BioScience Association Date: 07/26/2021
Dear Colorado Life Sciences Community, After almost five years at Colorado BioScience Association and more than two years as President & CEO, I have decided to transition from my role at CBSA to f...
Learn MoreColorado BioScience Association Announces Departure of President & CEO, Jennifer Jones Paton
By: Colorado BioScience Association Date: 07/26/2021
Board of Directors to Begin Comprehensive Search for Replacement DENVER – Colorado BioScience Association (CBSA) announced Jennifer Jones Paton’s plans to transition from her President & CEO role....
Learn MorePolicy + Advocacy: End-of-Session Report
By: Colorado BioScience Association Date: 07/15/2021
CBSA leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in o...
Learn MoreA Letter from Our President & CEO
By: Colorado BioScience Association Date: 07/12/2021
Colorado Life Sciences Community: Our ecosystem continues to demonstrate remarkable growth and innovation as we enter the second half of 2021. Medtronic broke ground on a new campus in Lafayette at th...
Learn MoreForesight Diagnostics Transforms Standard of Care for Disease Surveillance
By: Colorado BioScience Association Date: 06/29/2021
Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify p...
Learn MoreWeekly Policy Update: CBSA Signs BIO CEO Declaration on Global Access to COVID-19 Vaccines and Treatments and the Role of Intellectual Property
By: Colorado BioScience Association Date: 06/28/2021
Colorado BioScience Association (CBSA) and close to 300 other global biotechnology companies and associations have come together in opposition to waiving IP protections for COVID-19 vaccines and treat...
Learn MoreWeekly Policy Update: PASTEUR Act, COVID-19 Intellectual Property, and June Economic Forecast
By: Colorado BioScience Association Date: 06/21/2021
CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics Last week Senator Michael Bennet introduced new bipartisan legislation in the U.S. Senate that would s...
Learn MoreA Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session
By: Colorado BioScience Association Date: 06/14/2021
Dear Colorado Life Sciences Community, Colorado BioScience Association builds a collaborative, pro-innovation environment for life sciences innovation. Through our Policy + Advocacy efforts, we work a...
Learn MoreLegislative Session Closes – CBSA Reviews Policy Accomplishments
By: Colorado BioScience Association Date: 06/14/2021
The 2021 legislative session, the First Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that started during the heights of the COVID-19 pandemic and ended...
Learn More